{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Eli Lilly", "item": "https://www.patentleaderboard.com/2021/company/lilly"}, {"@type": "ListItem", "position": 4, "name": "Ryan James Linder", "item": "https://www.patentleaderboard.com/2021/inventor/fl:ry_ln:linder-1"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
RL

Ryan James Linder — 1 Patent in 2021

Eli Lilly: 1 patents #25 of 188Top 15%
Carmel, IN: #74 of 224 inventorsTop 35%
Indiana: #1,178 of 3,792 inventorsTop 35%
Overall (2021): #278,056 of 548,734Top 55%
1 Patents 2021

Issued Patents 2021

Showing 1–1 of 1 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
10968214 KRas G12C inhibitors David Anthony Barda, David Coates, Sheng-Bin Peng, Mohammad Sadegh Zia-Ebrahimi 2021-04-06 $1,544,764,000